201 – 210 of 320
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's disease
- Contribution to journal › Article
-
Mark
No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias
- Contribution to journal › Article
-
Mark
Development and characterisation of a novel rat model of Parkinson's disease induced by sequential intranigral administration of AAV-α-synuclein and the pesticide, rotenone.
- Contribution to journal › Article
-
Mark
Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates
- Contribution to journal › Article
-
Mark
Novel disease-specific promoters for use in gene therapy for Parkinson's disease.
- Contribution to journal › Article
-
Mark
Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain
- Contribution to journal › Scientific review
- 2011
-
Mark
Diagnosis and Treatment of Common Forms of Tremor
- Contribution to journal › Article
-
Mark
Heredity in Parkinson's disease. From rare mutations to common genetic risk factors.
- Thesis › Doctoral thesis (compilation)
-
Mark
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?
- Contribution to journal › Article
-
Mark
Microvascular plasticity and neurovascular coupling in the pharmacotherapy of Parkinson's disease
- Thesis › Doctoral thesis (compilation)
